Position in SPRY
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$2,746,596
-$1,901,276 QoQ
Shares Held
342,042
-14.3% QoQ
Ownership
0.344%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2020
22 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in SPRY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026FMR LLC holds $49,682,018,247 across 354 Biotechnology names. SPRY ranks #181 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
14,579,166 | $4,823,808,652 | |
| 2 | ARGX |
Argenx SE
|
4,991,034 | $3,644,702,577 | |
| 3 | MRNA |
Moderna, Inc.
|
45,672,024 | $2,320,138,818 | |
| 4 | ROIV |
Roivant Sciences Ltd.
|
77,981,253 | $2,160,080,705 | |
| 5 | INSM |
INSMED Inc
|
13,160,167 | $2,151,950,504 | |
| 6 | IONS |
Ionis Pharmaceuticals Inc
|
24,556,637 | $1,843,957,869 | |
| 7 | RPRX |
Royalty Pharma plc
|
25,152,242 | $1,206,553,046 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,518,192 | $1,173,015,865 |
All Filings in SPRY
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,746,596 | 342,042 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $4,647,872 | 398,959 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $7,462,205 | 742,508 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $27,344,323 | 1,567,010 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $12,465,018 | 990,860 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $11,628,473 | 1,102,225 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $15,751,567 | 1,086,315 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $9,236,056 | 1,085,318 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $11,087,902 | 1,084,922 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $6,588,685 | 1,202,315 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $4,941,744 | 1,307,340 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $31,254,011 | 4,664,778 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $33,124,525 | 5,088,253 | Shares | Defined | 2023-08-11 | |
| 2022-12-31 | $45,800,657 | 5,369,362 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $25,151,537 | 4,763,549 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $15,766,234 | 3,718,452 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $13,314,032 | 3,793,172 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $24,999,887 | 3,753,737 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $42,799,718 | 4,288,549 | Shares | Defined | 2022-02-14 | |
| 2021-06-30 | $144,811,331 | 4,687,968 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $210,539,139 | 4,825,559 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $159,470,027 | 3,441,304 | Shares | Defined | 2021-02-08 | |
| No filing history on record for this holder in this stock. | ||||||